Patent classifications
C
C12
C12N
2760/00
C12N2760/00011
C12N2760/18011
C12N2760/18611
C12N2760/18633
C12N2760/18633
Anticancer agent comprising HVJ-E and immune checkpoint protein inhibitor
11166995
·
2021-11-09
·
·
The present invention provides an anticancer agent containing the following (1) and (2): (1) HVJ-E (hemagglutinating virus of Japan envelope), (2) an inhibitor of an immune checkpoint protein.
ANTICANCER AGENT COMPRISING HVJ-E AND IMMUNE CHECKPOINT PROTEIN INHIBITOR
20190275091
·
2019-09-12
·
·
The present invention provides an anticancer agent containing the following (1) and (2): (1) HVJ-E (hemagglutinating virus of Japan envelope), (2) an inhibitor of an immune checkpoint protein.